Skip to main content

Table 5 Average cost and effectiveness results per 1000 patients – 2 years base case follow-up (patients with ≥5 retrieved oocytes)

From: Probabilistic cost-effectiveness analysis of controlled ovarian stimulation with recombinant FSH plus recombinant LH vs. human menopausal gonadotropin for women undergoing IVF

 

Medication cost

Monitoring cost

Miscarriage/pregnancy cost

Overall cost

Pregnancies

Cost per pregnancy

HP-hMG

€ 889,012

€ 967,508

€ 654,635

€ 2,511,155

339

€ 7400

r-FSH + r-LH

€ 1,690,582

€ 899,956

€ 894,236

€ 3,484,774

473

€ 7375

Difference

+€ 801,570

-€ 67,552

+€ 239,601

+€ 973,618

+ 133

-€ 25